Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.18%
#2 0G 0G +27.29%
#3 Pons Pons +26.97%
#4 SAFEcoin SAFEcoin +26.87%
#5 Zora Zora +25.96%
#6 Seeker Seeker +23.15%
#7 VVS Finance VVS Finance +21.62%
#8 Full Moon Full Moon +17.50%
#9 ADO Protocol ADO Protocol +16.58%
#10 Apertum Apertum +15.82%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Kedudukan dalam Saham #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Harga Saham
$4.99
Modal Pasaran
$508.03M
Perubahan (1 hari)
-2.48%
Perubahan (1 tahun)
2.10%
Negara
TW
Perdagangan Ever Supreme Bio Technology Co., Ltd (6712)

Kategori

Healthcare
Hasil untuk Ever Supreme Bio Technology Co., Ltd (6712)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Ever Supreme Bio Technology Co., Ltd, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Ever Supreme Bio Technology Co., Ltd dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH